Black Rock Inc. Sangamo Therapeutics, Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Black Rock Inc. holds 4,702,938 shares of SGMO stock, worth $11.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,702,938
Previous 13,277,637
64.58%
Holding current value
$11.8 Million
Previous $8.9 Million
80.97%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding SGMO
# of Institutions
115Shares Held
56.4MCall Options Held
576KPut Options Held
1.17M-
Wasatch Advisors Inc Salt Lake City, UT19.4MShares$48.6 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.6MShares$24 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.85MShares$12.1 Million0.01% of portfolio
-
Marshall Wace, LLP London, X02.35MShares$5.88 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.14MShares$5.35 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $391M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...